Pakistan’s Competition Commission Grants Approval for Acquisition The Competition Commission of Pakistan (CCP) has given the green light for International Investment Limited (IIL) to acquire Novartis Pharma (Pakistan) Limited. The decision comes after the CCP completed its Phase-I competition assessment under Section 11 of the Competition Act, signaling a structured review of how the deal…